David Morgenstern

Absence of Respiratory Burst in X-linked Chronic Granulomatous Disease Mice Leads to Abnormalities in Both Host Defense and Inflammatory Response to <i>Aspergillus fumigatus</i>

David Morgenstern, Mary A. Gifford, Ling Lin Li et al. · The Journal of Experimental Medicine · 1997 · 370 citations · Full text

Life Sciences, Immunology, Microbiology +17

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial

Benjamin A. Lipsky, David G. Armstrong, Diane M. Citron et al. · The Lancet · 2005 · 268 citations

Health Professions, Infectious Diseases, Pharmacology +16

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

R. Wendel Naumann, Robert L. Coleman, Robert A. Burger et al. · Journal of Clinical Oncology · 2013 · 233 citations

Medicine, Oncology, Pharmacology +16

Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice

Linda B. Adams, Mary C. Dinauer, David Morgenstern et al. · Tubercle and Lung Disease · 1997 · 188 citations

Life Sciences, Immunology, Microbiology +16

Exploratory Study of ^99mTc-EC20 Imaging for Identifying Patients with Folate Receptor–Positive Solid Tumors

Ronald E. Fisher, Barry A. Siegel, Steven L. Edell et al. · Journal of Nuclear Medicine · 2008 · 142 citations · Full text

Medicine, Nuclear Medicine, Oncology +17